(PubMed) Izzo AA, Ernst E
Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer
The animal science is solid, but no large human trials have been completed, it's not FDA-approved, and the company that developed it walked away from it in the early 2000s
At Perfect B, gut-focused protocols typically use oral or troche formats that deliver BPC-157 directly to the gastrointestinal tract, while musculoskeletal protocols use subcutaneous injection near the target tissue or in the abdominal fat pad for systemic delivery
O., Bera, K., Keys, J., Li, Y., Tuntithavornwat, S., et al